NCT03149627View on ClinicalTrials.gov

Chronic Hepatitis B Virus Clinical Epidemiology in a Representative Sample of Zambian Adults

CompletedOBSERVATIONAL
Enrollment

5,003

Participants

Timeline

Start Date

June 7, 2017

Primary Completion Date

December 19, 2018

Study Completion Date

December 19, 2018

Conditions
HBVAlcoholic HepatitisLiver Fibroses
Interventions
OTHER

Estimates - prevalence of lifetime/chronic HBV infection

Estimation of the prevalence and correlates of lifetime HBV infection defined as hepatitis B core antibody (HBcAb) positivity and chronic HBV infection defined as HBsAg positivity.

Trial Locations (1)

Unknown

University Teaching Hospital, Lusaka

All Listed Sponsors
collaborator

University Teaching Hospital

UNKNOWN

collaborator

Tropical Gastroenterology and Nutrition Group

UNKNOWN

collaborator

Centre for Infectious Disease Research in Zambia

OTHER

collaborator

Ministry of Health, Zambia

OTHER_GOV

lead

University of Alabama at Birmingham

OTHER

NCT03149627 - Chronic Hepatitis B Virus Clinical Epidemiology in a Representative Sample of Zambian Adults | Biotech Hunter | Biotech Hunter